Dr. Lucie Germain, Ph.D., is a full professor at the Department of Surgery and Vice Dean of Research and Graduate Studies at Laval University. Within the CHU de Québec-Laval University Research Center, she was Director of the Regenerative Medicine Division until 2014. Her work, dedicated to postnatal stem cells and human tissue reconstruction, led to three clinical trials involving engineered tissues produced in vitro applied to the treatment of venous ulcers, severely burned patients and limbal stem cell deficiency of the cornea. Dr. Germain has published more than 155 peer-reviewed articles, 67 book chapters and reviews and given more than 135 invited seminars and conferences. Her sustainable contribution as health research was recognized by the Foundation scheme of Canadian Institutes of Health Research, which allowed her a financial support for seven years in 2015. The Canada research chair program also recognized Dr. Germain as a leader in the field of stem cells and regenerative medicine by granting her a junior Tier-2 chair in 2001 and a senior Tier 1 chair in 2015. In 2013, she was nominated Member of the Canadian Academy of Health Sciences and was appointed Vice-Dean of Research and Graduate Studies at the Faculty of Medicine of Laval University in 2014.

Improving patients care through the application of her research is at the heart of her motivations. She holds the Research Chair on tissue-engineered organs and translational medicine from the Foundation of Laval University. Her research is dedicated to the reconstruction of human tissues, mainly skin, cornea, blood vessels and heart valves for experimental and clinical applications. The tissue-engineered models developed by Dr. Germain are designed for physiological, pathophysiological or pharmacotoxicological studies. Her research aims to better define molecular signaling pathways involved in stem cell regulation and differentiation. Her work also focuses on improving functionality of reconstructed tissues, for example by adding melanocytes to skin substitutes to improve their pigmentation and UV protection. An important part of her research aims to shorten the time required to produce skin substitutes and to develop a serum-free culture medium for cell and tissue culture. Finally, Dr. Germain actively works on strategies aimed at integrating tissue engineering and gene therapy to find new treatments for genetic skin disorders such as epidermolysis bullosa.

1401, 18e Rue
Local: R-109, LOEX/ CMDGT
Québec, Québec
Canada G1J 1Z4
+1 418-990-8255, extension 61696
+1 418-990-8237
Lucie.germain@fmed.ulaval...

Latest news

211 entries « ‹ 1 of 22 › »

Kawecki F, Mayrand D, Ayoub A, Attiogbe E, Germain L, Auger FA, Moulin VJ

Biofabrication and preclinical evaluation of a large-sized human self-assembled skin substitute.

Journal Article

Biomed Mater, 2020, ISSN: 1748-6041.

Abstract | Links:

Tong Y, Febrer G, Mao J, Wawryko P, Mao Y, Le-Bel G, How D, Philippe E, Zhou T, Zhang Z, Wang L, Germain L, Guidoin R

Limb salvage after aneurysmal degeneration of a cryopreserved vein allograft: Searching the autologous veins of the arm is worth the effort.

Journal Article

Morphologie, 104 (346), pp. 202-213, 2020, ISSN: 1286-0115.

Abstract | Links:

Larose A, Dakiw-Piaceski A, Barbier MA, Larouche D, Gauvin R, Caruso M, Pope E, Germain L

Peel Test to Assess the Adhesion Strength of the Dermal-Epidermal Junction in Tissue-Engineered Skin.

Journal Article

Tissue Eng Part C Methods, 26 (3), pp. 180-189, 2020, ISSN: 1937-3384.

Abstract | Links:

Roy V, Magne B, Vaillancourt-Audet M, Blais M, Chabaud S, Grammond E, Piquet L, Fradette J, Laverdiere I, Moulin VJ, Landreville S, Germain L, Auger FA, Gros-Louis F, Bolduc S

Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors.

Journal Article

Biomed Res Int, 2020 , pp. 6051210, 2020.

Abstract | Links:

Le-Bel G, Desjardins P, Couture C, Germain L, Guerin SL

The Self-assembly Approach as a Tool for the Tissue Engineering of a Bi-lamellar Human Cornea.

Journal Article

Methods Mol Biol, 2145 , pp. 103-118, 2020, ISSN: 1064-3745.

Abstract | Links:

Le-Bel G, Cortez Ghio S, Guerin LP, Bisson F, Germain L, Guerin SL

Irradiated Human Fibroblasts as a Substitute Feeder Layer to Irradiated Mouse 3T3 for the Culture of Human Corneal Epithelial Cells: Impact on the Stability of the Transcription Factors Sp1 and NFI.

Journal Article

Int J Mol Sci, 20 (24), 2019.

Abstract | Links:

Mao J, Rassoli A, Tong Y, Rouse EN, Le-Bel G, How D, Germain L, Fatouraee N, Zhang Z, Reed RR, Guidoin R

Donkey pericardium compares favorably with commercial xenopericardia used in the manufacture of transcatheter heart valves.

Journal Article

Artif Organs, 43 (10), pp. 976-987, 2019, ISSN: 0160-564X.

Abstract | Links:

Ghani K, Boivin-Welch M, Roy S, Dakiw-Piaceski A, Barbier M, Pope E, Germain L, Caruso M

Generation of High-Titer Self-Inactivated γ-Retroviral Vector Producer Cells.

Journal Article

Mol Ther Methods Clin Dev, 14 , pp. 90-99, 2019, ISSN: 2329-0501.

Abstract | Links:

Le-Bel G, Guerin LP, Carrier P, Mouriaux F, Germain L, Guerin SL, Bazin R

Grafting of an autologous tissue-engineered human corneal epithelium to a patient with limbal stem cell deficiency (LSCD).

Journal Article

Am J Ophthalmol Case Rep, 15 , pp. 100532, 2019, ISSN: 2451-9936.

Abstract | Links:

Meng S, Mao J, Rouse EN, Le-Bel G, Bourget JM, Reed RR, Philippe E, How D, Zhang Z, Germain L, Guidoin R

The Red Kangaroo pericardium as a material source for the manufacture of percutaneous heart valves.

Journal Article

Morphologie, 103 (341), pp. 37-47, 2019, ISSN: 1286-0115.

Abstract | Links:

211 entries « ‹ 1 of 22 › »
Signaler des ajouts ou des modifications

Active projects

  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • Centre de recherche en organogenèse expérimentale, Subvention, Institutionnel - BDR, BDR - Centres de recherche reconnus, from 2011-05-01 to 2020-12-31
  • Chaire de recherche du Canada EN CELLULES SOUCHES ET GÉNIE TISSULAIRE, Subvention, Secrétariat des Chaires de recherche du Canada, Chaires de recherche du Canada - Fonctionnement, from 2015-01-01 to 2021-12-31
  • Chaire de recherche sur les organes reconstruits en laboratoire et leurs applications cliniques, Subvention, Fondation de l'Université Laval, Chaires de recherche sans organismes subventionnaires, from 2013-05-01 to 2023-08-12
  • Cultured epithelial corneal autografts for the treatment of canadians with limbal stem cell deficiency, Subvention, Secrétariat Inter-Conseils (Canada) (CRSH, CRSNG, IRSC), Réseau de centres d'excellence (RCE), from 2020-01-01 to 2022-01-31
  • Évaluation de la qualité, de la structure et des propriétés fonctionnelles des peaux reconstruites par génie tissulaire, Partenariat, MITACS Inc., Accélération Québec (MITACS/MEIE), from 2019-09-01 to 2021-06-30
  • Les cellules souches épithéliales et le génie tissulaire : de la recherche fondamentale à la recherche clinique., Subvention, Instituts de recherche en santé du Canada, Subventions Fondation, from 2015-07-01 to 2022-06-30
  • Self-Assembly Skin Substitutes (SASS) for the treatment of acute wounds of Canadian burn patients, Subvention, Secrétariat Inter-Conseils (Canada) (CRSH, CRSNG, IRSC), Réseau de centres d'excellence (RCE), from 2020-01-01 to 2022-01-31
  • Soutien à la recherche dans le domaine des maladies auto-immunes et de la cicatrisation, Subvention, Fondation de l'Université Laval, from 2016-04-01 to 2021-03-31
  • The Canadian National Transplant Research Program : Increasing Donation and Improving Transplantation Outcomes, Subvention, Instituts de recherche en santé du Canada, Autre : Recherche sur la transplantation, from 2013-04-01 to 2022-03-31

Recently finished projects

  • Development of skin-humanized mouse model for psoriasis, Partenariat, MITACS Inc., Bourse de recherche Mitacs Globalink, from 2019-01-07 to 2019-08-23
  • Feasability stuy on the production of skin substitutes from revertant gene corrected cells from DEB patients, Subvention, Epidermolysis Bullosa Medical Research Foundation, from 2018-04-25 to 2019-04-24
  • Gene therapy for junctional epidermolysis bullosa, Subvention, Le Grand Défi Pierre Lavoie, Subvention pour projet de recherche sur une maladie héréditaire orpheline, from 2018-10-01 to 2019-09-30
  • Journée de la recherche de la Faculté de médecine, Subvention, Institutionnel - BDR, Fonds général de recherche du CRSNG, from 2010-11-24 to 2020-03-31
  • Le développement d’une thérapie génique efficace et sécuritaire pour l’épidermolyse bulleuse récessive dystrophique et jonctionnelle. , Subvention, Fonds de recherche du Québec - Santé, Réseaux thématiques de recherche, from 2019-04-01 to 2020-03-31
Data provided by the Université Laval research projects registery